In this roundtable, investors will delve into the intricacies of market dynamics and the constantly evolving pharmaceutical and biotech investment climate. By delving into these nuanced topics, attendees will become equipped with a deeper understanding of market dynamics, investment climate challenges, and strategic considerations essential for successful investments in the pharmaceutical and biotech sectors.

• Identifying areas of significant M&A activity and emerging investment opportunities in life sciences IP
• Considering strategic alliances and royalty monetization
• Outlining what investors wish inventors knew before coming to the table
• What do investors want to see in patents and IP strategy?
• What non-IP factors are the most important?
• When is the strength of the patent the bottom line and when do other factors (such as regulatory exclusivity or clinical trial results) prevail?
• Identifying areas of significant M&A activity and emerging investment opportunities in life sciences IP
• Demystifying investor risk assessment, preferences and their target areas for investment or acquisition
• What financial valuation methods do investors use?
• Navigating the balance between risk mitigation and growth potential
• Examining the unique challenges faced by biotech companies in securing funding
• Uncovering strategies to enhance capital availability and attract investor interest
• Appreciating how investors are considering the impact of the price control provisions on IP under Inflation Reduction Act in today’s deal-making.
• How are price controls and patents linked?
• Assessing the dynamics and benefits of investor involvement in different stages of company growth